[go: up one dir, main page]

YU37113B - Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine - Google Patents

Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Info

Publication number
YU37113B
YU37113B YU3212/79A YU321279A YU37113B YU 37113 B YU37113 B YU 37113B YU 3212/79 A YU3212/79 A YU 3212/79A YU 321279 A YU321279 A YU 321279A YU 37113 B YU37113 B YU 37113B
Authority
YU
Yugoslavia
Prior art keywords
ethylamine
dimethoxy
beta
phenyl
obtaining substituted
Prior art date
Application number
YU3212/79A
Other languages
English (en)
Other versions
YU321279A (en
Inventor
R R Tuttle
J Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU37113(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU321279A publication Critical patent/YU321279A/xx
Publication of YU37113B publication Critical patent/YU37113B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU3212/79A 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine YU37113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
YU321279A YU321279A (en) 1983-04-27
YU37113B true YU37113B (en) 1984-08-31

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines
YU3212/79A YU37113B (en) 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines

Country Status (31)

Country Link
JP (2) JPS5825656B2 (xx)
KR (1) KR790000113B1 (xx)
AR (1) AR203822A1 (xx)
AT (1) AT323719B (xx)
AU (1) AU472734B2 (xx)
BE (1) BE798051A (xx)
BG (1) BG23001A3 (xx)
CA (1) CA1018188A (xx)
CH (2) CH580563A5 (xx)
CS (2) CS190406B2 (xx)
CY (1) CY963A (xx)
DD (1) DD107670B3 (xx)
DE (1) DE2317710C2 (xx)
DK (1) DK142750C (xx)
ES (1) ES413639A1 (xx)
FR (1) FR2182947B1 (xx)
GB (1) GB1392674A (xx)
HK (1) HK50178A (xx)
HU (2) HU166213B (xx)
IE (1) IE37511B1 (xx)
IL (1) IL42016A (xx)
KE (1) KE2870A (xx)
MY (1) MY7800381A (xx)
NL (1) NL174459C (xx)
PH (1) PH11041A (xx)
PL (2) PL90695B1 (xx)
RO (2) RO65105A (xx)
SE (1) SE399064B (xx)
SU (1) SU496719A3 (xx)
YU (2) YU36483B (xx)
ZA (1) ZA732136B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (xx) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
EP0071399A3 (en) * 1981-07-22 1983-12-07 Syntex (U.S.A.) Inc. Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (xx) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
CA2500935C (en) 2002-10-03 2014-09-23 New Era Biotech, Ltd. Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
JP4939396B2 (ja) 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Aids及び他のウイルス性疾患及びhiv関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
RU2012107457A (ru) 2009-07-31 2013-09-10 Когнишн Терапьютикс, Инк. Ингибиторы ухудшения когнитивных способностей
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
WO2013029057A2 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
BR112016017808B1 (pt) 2014-01-31 2022-07-12 Cognition Therapeutics, Inc Composto ou sal farmaceuticamente aceitável, uso de um composto e composição para a inibição de um efeito betaamilóide numa célula neuronal
BR112019023851A2 (pt) 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实(湖南)医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
CS190406B2 (en) 1979-05-31
HU166213B (xx) 1975-02-28
BG23001A3 (bg) 1977-05-20
KR790000113B1 (en) 1979-03-20
HU167597B (xx) 1975-11-28
DK142750C (da) 1981-08-17
JPS497237A (xx) 1974-01-22
RO65105A (ro) 1980-01-15
DE2317710A1 (de) 1973-10-18
JPS6221343B2 (xx) 1987-05-12
DK142750B (da) 1981-01-12
FR2182947B1 (xx) 1976-07-02
DD107670B3 (de) 1988-04-06
NL174459C (nl) 1984-06-18
DD107670A5 (de) 1974-08-12
CY963A (en) 1978-12-22
SE399064B (sv) 1978-01-30
BE798051A (fr) 1973-10-11
ES413639A1 (es) 1976-01-16
YU97673A (en) 1982-02-25
DE2317710C2 (de) 1983-08-04
IL42016A (en) 1976-05-31
FR2182947A1 (xx) 1973-12-14
JPS5825656B2 (ja) 1983-05-28
CH580563A5 (xx) 1976-10-15
CA1018188A (en) 1977-09-27
AU5438573A (en) 1974-10-17
PL90695B1 (xx) 1977-01-31
SU496719A3 (ru) 1975-12-25
RO70892A (ro) 1982-02-26
IE37511B1 (en) 1977-08-03
PL94207B1 (xx) 1977-07-30
GB1392674A (en) 1975-04-30
ZA732136B (en) 1974-03-27
IL42016A0 (en) 1973-06-29
PH11041A (en) 1977-10-25
MY7800381A (en) 1978-12-31
CH569691A5 (xx) 1975-11-28
JPS58131945A (ja) 1983-08-06
KE2870A (en) 1978-09-01
AR203822A1 (es) 1975-10-31
NL7305097A (xx) 1973-10-16
YU321279A (en) 1983-04-27
AT323719B (de) 1975-07-25
HK50178A (en) 1978-09-15
CS190448B2 (en) 1979-05-31
YU36483B (en) 1984-02-29
NL174459B (nl) 1984-01-16
AU472734B2 (en) 1976-06-03

Similar Documents

Publication Publication Date Title
YU254979A (en) Process for preparing new 3,4-dihydrocarbostyryl-derivatives
YU37113B (en) Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine
YU39715B (en) Process for obtaining substituted omega-pentanoprostaglandins
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
YU39297B (en) Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones
YU35243B (en) Process for obtaining diphenylyl-alkanoyl-aminopyridines
YU310573A (en) Process for obtaining 3-hydroxycephalosporins
YU35452B (en) Process for obtaining d-homosteroids
YU40095B (en) Process for obtaining 1,2-dialkyl-3,5-diphenylpirazolium salts
YU98273A (en) Process for obtaining isopropylamines
YU269273A (en) Process for obtaining 2,10-dichloro-12-methyl-12h-dibenzo (d.g.)-(1,3)dioxocines
YU210473A (en) Process for obtaining novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
YU219673A (en) Process for obtaining 15 delta, 16-methylene-4-pregnene
YU229979A (en) Process for obtaining novel 1,4-benzodixane derivatives
YU318473A (en) Process for obtaining m-dioxane-5-methylamines
YU146973A (en) Process for obtaining oxo-prostaglandins
YU49973A (en) Process for obtaining n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine
YU36701B (en) Process for obtaining as-triazinoz5,6-ccquinoline derivatives
YU36972B (en) Process for obtaining 7-acylamido-7-alkoxycephalosporins
YU240180A (en) Process for obtaining deacetoxy-cephalosporin
YU35273B (en) Process for obtaining bicyclomycine
CS191448B1 (en) Process for preparing 6,7-dihydrobenztrazole
YU45373A (en) Process for preparing 6,9-dioxo-8-hydroxy-2-(3,4-dihydroxyphenyl)-bicyclo-(3,3,1)-7-nomene-3-01
YU34896B (en) Process for preparing substituted 2-aryla inoimidazolines-(2)
YU39001B (en) Process for preparing new 3,4-dihydrocarbostyryl derivatives